title: Oral non-Hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
abstract: Oral non-Hodgkin's lymphomas (O-NHLs) are a rare group of diverse lymphoid tissue malignancies and represent less than 5% of the oral cavity malignancies and 2% of all extra-nodal NHLs. Oral-NHLs affect the Waldeyer's-ring, the salivary glands, the bone of the jaws and the oral mucosa, their clinical appearance is very heterogeneous. Among the risk factors for NHLs are immunosuppression (primary or secondary), autoimmunity and inflammation. O-NHLs share the same risk factors. This case report describes a patient with O-NHL which was possibly linked to the combination of methotrexate and etanercept for the treatment of her rheumatoid arthritis. To our knowledge this is probably among the first cases of O-NHL with possible relation to the use of a Tumor Necrosis Factor (TNF) antagonist biological agent (etanercept). This case could contribute to the sensitization of the dentists for the signs and symptoms of this rare malignancy. It also underlines the need for thorough medical history and medication recording for all the dental patients. Key words:Lymphoma (oral) methotrexate, etanercept.
authors: MD, DDS, MSc, PhD. Oral Medicine Specialist.
authors: Eleni A
authors: EA
authors: Georgakopoulou
authors: DDS, MS. Dental Clinic, General Hospital Paidon Pentelis, Athens, Greece.
authors: Marina D
authors: MD
authors: Achtari
authors: MD, PhD, Pathologist. Department of Histology and Embryology, School of Medicine, University of Athens, Greece.
authors: Kostas
authors: K
authors: Evangelou
authors: MD, PhD, Pathologist. Department of Histology and Embryology, School of Medicine, University of Athens, Greece.
authors: Christos
authors: C
authors: Kittas